August 30, 2012
Japan Tobacco (JT) and its subsidiary Torii Pharmaceutical announced on August 28 that they reached an agreement on the same day that Torii will exclusively market in Japan a new fixed-dose combination drug containing JT’s novel anti-HIV drug JTK-303 (elvitegravir),...read more